Acquired platelet dysfunction in patients with uremia.
The current status of knowledge of the uremic hemorrhagic diathesis is reviewed. Discussions of clinical features, classification and pathogenesis, retention products and hemostatic defects, and therapy are included.
Carvalho
A C
AC
Brown University, Providence, Rhode Island.
D001779:Blood Coagulation Factors / Q000378:metabolism; D001791:Blood Platelet Disorders / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D003131:Combined Modality Therapy; D004730:Endothelium, Vascular / Q000293:injuries / Q000378:metabolism; D006801:Humans; D015539:Platelet Activation; D010976:Platelet Count; D010979:Platelet Function Tests; D011453:Prostaglandins / Q000378:metabolism; D013931:Thromboxanes / Q000378:metabolism; D014511:Uremia / Q000150:complications*
D001779:Blood Coagulation Factors; D011453:Prostaglandins; D013931:Thromboxanes